The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

UCSF scientists engineered old fibroblast cells to turn their genes on and off in the same way as young fibroblasts. The old ...

More than 9 out of 10 Alzheimer's cases could be driven by specific variations in a single gene and the protein it produces, ...

In a groundbreaking study published in the in Proceedings of the National Academy of Sciences (PNAS), scientists at Pacific ...

A new LUMC study has changed our understanding of how cells work. Researchers have discovered that the CFAP20 protein acts as ...

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...

We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

Attention can feel like a fragile thing, especially when your brain struggles to sort signal from noise. Every second, your ...

For those born with certain types of congenital deafness, the cochlear implant has been a positive and enabling technology.

Researchers from Radboud university medical center and University of Basel have discovered new genetic causes of inherited ...